1 – 47 of 47
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer
(
- Contribution to journal › Article
- 2021
-
Mark
A population-based study on the effect of a routine second-look resection on survival in primary stage T1 bladder cancer
(
- Contribution to journal › Article
- 2019
-
Mark
Management and outcome of TaG3 tumours of the urinary bladder in the nationwide, population-based bladder cancer database Sweden (BladderBaSe)
(
- Contribution to journal › Article
- 2016
-
Mark
Carl-Gustaf Bergstrand (1914–2011), former Managing Editor of Acta Paediatrica
(
- Contribution to journal › Article
- 2009
-
Mark
Brain tumours in children.
(
- Contribution to journal › Article
- 2008
-
Mark
Asn1421Lys mutation in the glycoprotein Ib binding domain impairs - ristocetin and botrocetin - mediated binding of von Willebrand factor to platelets
2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.116-116(
- Contribution to journal › Published meeting abstract
-
Mark
Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
(
- Contribution to journal › Article
-
Mark
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)
(
- Contribution to journal › Article
-
Mark
N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
(
- Contribution to journal › Article
-
Mark
Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease.
(
- Contribution to journal › Article
-
Mark
Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD
(
- Contribution to journal › Article
- 2007
-
Mark
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)
(
- Contribution to journal › Article
-
Mark
Residual adverse changes in arterial endothelial function and LDL oxidation after a mild systemic inflammation induced by influenza vaccination
(
- Contribution to journal › Article
-
Mark
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)
(
- Contribution to journal › Article
-
Mark
ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura.
(
- Contribution to journal › Article
-
Mark
Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura
(
- Contribution to journal › Article
- 2006
-
Mark
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
(
- Contribution to journal › Scientific review
-
Mark
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)
(
- Contribution to journal › Article
-
Mark
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD
(
- Contribution to journal › Article
-
Mark
Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome.
(
- Contribution to journal › Article
- 2005
-
Mark
VWF-cleaving protease (ADAMTS13) in premature infants.
(
- Contribution to journal › Article
- 2004
-
Mark
Sorting of Von Willebrand factor to lysosome-related granules of haematopoietic cells
(
- Contribution to journal › Article
- 2003
-
Mark
Desmopressin (DDAVP) and factor VIII
(
- Contribution to journal › Debate/Note/Editorial
- 2002
-
Mark
Predictors of deterioration of lung function in cystic fibrosis.
(
- Contribution to journal › Article
-
Mark
Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X).
(
- Contribution to journal › Article
- 2001
-
Mark
Symposium in memory of Professor Inga Marie Nilsson
(
- Contribution to journal › Published meeting abstract
- 1997
-
Mark
von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura
(
- Contribution to journal › Article
-
Mark
Bernard-Soulier syndrome Karlstad : Trp 498-->Stop mutation resulting in a truncated glycoprotein Ib alpha that contains part of the transmembranous domain
(
- Contribution to journal › Article
- 1996
-
Mark
Increased platelet retention in familial recurrent thrombotic thrombocytopenic purpura
(
- Contribution to journal › Article
- 1992
-
Mark
Cerebral infarction in a girl who developed anticardiolipin syndrome after acute lymphoblastic leukemia
(
- Contribution to journal › Article
- 1991
-
Mark
Moderate haemophilia B in a female carrier caused by preferential inactivation of the paternal X chromosome
(
- Contribution to journal › Article
- 1990
-
Mark
Platelet surface-bound IgG and platelet-specific IgG in plasma in childhood thrombocytopenia
(
- Contribution to journal › Article
- 1987
-
Mark
Prenataldiagnostik av hemofili A och B genom chorionvillus-biopsi och DNA-analys.
(
- Contribution to journal › Article
- 1986
-
Mark
Platelet-associated IgG in childhood idiopathic thrombocytopenic purpura : measurements on intact and solubilized platelets and after gammaglobulin treatment
(
- Contribution to journal › Article
- 1985
-
Mark
Polymorphism of normal factor IX detected by mouse monoclonal antibodies
1985) In Proceedings of the National Academy of Sciences of the United States of America 82(11). p.3839-3843(
- Contribution to journal › Article
- 1983
-
Mark
Detection of factor IX inhibitors by immunoradiometric assay
(
- Contribution to journal › Article
-
Mark
Suppression of Secondary Antibody Response by Intravenous Immunoglobulin in a Patient with Haemophilia B and Antibodies
(
- Contribution to journal › Article
-
Mark
The effects of plasmin and protein Ca on factor VIII:C and VIII:CAg
(
- Contribution to journal › Article
- 1982
-
Mark
Haemophilia A and B--two years experience of genetic counselling and prenatal diagnosis
(
- Contribution to journal › Article
-
Mark
Immunoradiometric assay of inhibitors of antihaemophilic factor A
(
- Contribution to journal › Article
-
Mark
Genetic variants of haemophilia B detected by immunoradiometric assay : implications for prenatal diagnosis
(
- Contribution to journal › Article
- 1981
-
Mark
F VIII:CAg in Haemophilia A. A comparison between IRMA:s using haemophilic and spontaneous antibodies
(
- Contribution to journal › Article
-
Mark
Inheritable molecular variants of moderate and mild hemophilia A
(
- Contribution to journal › Article
- 1980
-
Mark
Prenatal diagnosis of hemophilia B by an immunoradiometric assay of factor IX
(
- Contribution to journal › Article
- 1979
-
Mark
Measurement of antihaemophilic factor A antigen (VII:CAg) with a solid phase immunoradiometric method based on homologous non-haemophilic antibodies.
(
- Contribution to journal › Article
-
Mark
Fanconi's anaemia associated with haemophilia A
(
- Contribution to journal › Article
- 1978
-
Mark
Purification of F.VIII:C by antigen-antibody chromatography
(
- Contribution to journal › Article